These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 31579944)

  • 21. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.
    Zhou X; Zang X; Ponnusamy M; Masucci MV; Tolbert E; Gong R; Zhao TC; Liu N; Bayliss G; Dworkin LD; Zhuang S
    J Am Soc Nephrol; 2016 Jul; 27(7):2092-108. PubMed ID: 26701983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in Colorectal Carcinoma Cells.
    Jacksi M; Schad E; Tantos A
    Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of EZH2 mitigates peritoneal fibrosis and lipid precipitation in peritoneal mesothelial cells mediated by klotho.
    Wang Q; Sun J; Wang R; Sun J
    Ren Fail; 2023 Dec; 45(1):2149411. PubMed ID: 36724065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WNT signaling is required for peritoneal membrane angiogenesis.
    Padwal M; Cheng G; Liu L; Boivin F; Gangji AS; Brimble KS; Bridgewater D; Margetts PJ
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1036-F1045. PubMed ID: 29363326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
    Ferrantelli E; Liappas G; Vila Cuenca M; Keuning ED; Foster TL; Vervloet MG; Lopéz-Cabrera M; Beelen RH
    Kidney Int; 2016 Mar; 89(3):625-35. PubMed ID: 26880457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and significance of SIRT6 in human peritoneal dialysis effluents and peritoneal mesothelial cells.
    Shi SS; Zhang YQ; Zhang LQ; Li YF; Zhou XS; Li RS
    Int Urol Nephrol; 2024 Aug; 56(8):2659-2670. PubMed ID: 38483736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empagliflozin attenuates epithelial-to-mesenchymal transition through senescence in peritoneal dialysis.
    Lho Y; Park Y; Do JY; Kim AY; Park YE; Kang SH
    Am J Physiol Renal Physiol; 2024 Sep; 327(3):F363-F372. PubMed ID: 38961839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
    Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
    Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
    Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
    Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling.
    Ueno T; Nakashima A; Doi S; Kawamoto T; Honda K; Yokoyama Y; Doi T; Higashi Y; Yorioka N; Kato Y; Kohno N; Masaki T
    Kidney Int; 2013 Aug; 84(2):297-307. PubMed ID: 23486522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apigenin suppresses mouse peritoneal fibrosis by down-regulating miR34a expression.
    Zhang Y; Sun Q; Li X; Ma X; Li Y; Jiao Z; Yang XD
    Biomed Pharmacother; 2018 Oct; 106():373-380. PubMed ID: 29966983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suramin inhibits the development and progression of peritoneal fibrosis.
    Xiong C; Liu N; Fang L; Zhuang S; Yan H
    J Pharmacol Exp Ther; 2014 Nov; 351(2):373-82. PubMed ID: 25168661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice.
    Yokoi H; Kasahara M; Mori K; Kuwabara T; Toda N; Yamada R; Namoto S; Yamamoto T; Seki N; Souma N; Yamaguchi T; Sugawara A; Mukoyama M; Nakao K
    Perit Dial Int; 2013; 33(2):143-54. PubMed ID: 23123666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
    Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
    J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
    Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
    Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ST2 blockade mitigates peritoneal fibrosis induced by TGF-β and high glucose.
    Kim YC; Kim KH; Lee S; Jo JW; Park JY; Park MS; Tsogbadrakh B; Lee JP; Lee JW; Kim DK; Oh KH; Jang IJ; Kim YS; Cha RH; Yang SH
    J Cell Mol Med; 2019 Oct; 23(10):6872-6884. PubMed ID: 31397957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Antitumoral Effect of the S-Adenosylhomocysteine Hydrolase Inhibitor, 3-Deazaneplanocin A, is Independent of EZH2 but is Correlated with EGFR Downregulation in Chondrosarcomas.
    Aury-Landas J; Girard N; Lhuissier E; Adouane D; Delépée R; Boumediene K; Baugé C
    Cell Physiol Biochem; 2019; 53(4):731-745. PubMed ID: 31613064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GSK343, an inhibitor of EZH2, mitigates fibrosis and inflammation mediated by HIF-1α in human peritoneal mesothelial cells treated with high glucose.
    Wang Q; Xu L; Zhang X; Liu D; Wang R
    Eur J Pharmacol; 2020 Aug; 880():173076. PubMed ID: 32222493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.
    Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L
    Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.